BRIEF-AstraZeneca Says Forxiga Approved In Japan For Heart Failure
30 Nov 2020 / 15:50 H.
Nov 30 (Reuters) - AstraZeneca PLC:
* ASTRAZENECA PLC - FORXIGA APPROVED IN JAPAN FOR HEART FAILURE
* ASTRAZENECA- FORXIGA (DAPAGLIFLOZIN) APPROVED IN JAPAN FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE (HF) WHO ARE RECEIVING STANDARD OF CARE
* ASTRAZENECA- APPROVAL WAS BASED ON POSITIVE RESULTS FROM LANDMARK DAPA-HF PHASE III TRIAL Source text for Eikon: Further company coverage:
Did you like this article?
